A unique challenge is emerging in the search for a COVID-19 vaccine: how to balance intellectual property rights with serving the public good.
Amazon and General Motors are among companies exploring ways to test employees for COVID-19 infection, but these measures may be against the law.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It's based on a vaccine that was already in development for influenza, and has shown promise in animal studies.
Long after a crisis recedes, residual anxiety can remain and become calcified in cultures, customs and institutions.
Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.
Do recent lockdown protests indicate that Australia is on the path to Trump's America? While we can currently rest easy, the problem requires careful consideration.
Delaying medical care comes at a cost, both human and financial. The patients some emergency rooms have been seeing are a lot sicker and more likely to need hospitalization.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
We don't have vaccines for the Sars, Mers or the common cold. But that doesn't mean scientists won't crack it this time.
Army physicians are turning to drugs approved for other conditions or newly developed treatments such as the antiviral Remdesivir to treat infected personnel.
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
A vaccine historically used to prevent tuberculosis is now among the contenders for a COVID-19 vaccine. So what is the BCG vaccine and why might it work against coronavirus?
COVID-19 and SARS are both deadly – but different. SARS symptoms were quick to appear, making it easier to contain. Because health officials were able to contain it, the virus died off.
This week we've been looking at the factors in play when considering to ease lockdowns, how the massive costs can be met, and the ongoing search for treatments.
These strategies for easing needle pain and fear make vaccinations and other injections easier for parents and children. They are simple and helpful for all ages, from infants to adults.
A vaccine is at least a year away, but we need to start thinking about how we will roll it out now.
To refuse inclusion would prevent Africa’s researchers from being significant players in the universal fight against the virus.
They're conducting research, accommodating testing facilities and turning dorms into quarters for medical professionals while also helping people muddle through hard ethical decisions.
Vaccines for other diseases are being examined for their protective effects against coronavirus.
It is impossible to anticipate if, how or when COVID-19 might take a loved one. But there are ways to prepare.